POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC | N212832 | FRESENIUS KABI USA LLC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2025-00731 | 11925661 | IPR | Amneal Pharmaceuticals, Inc. et al. | Discretionary Denial | 2025-04-11 | 2025-09-03 |
| IPR2025-00779 | 11813291 | IPR | Amneal Pharmaceuticals, Inc. | Discretionary Denial | 2025-04-11 | 2025-09-03 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Nivagen Pharmaceuticals, Inc. v. Amneal Pharmaceuticals Inc. et al 2 patentsPotassium phosphates in sodium chloride | D. Del. | 2024-07-19 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.